Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
CardioRenal logo — Digital therapeutics for chronic cardiovascular disease

CardioRenal

Digital therapeutics for chronic cardiovascular disease

Founded 2013 France France 2 employees Seed Total: $3.30M Biotechnology, Health Care +1

General Information

Company Name CardioRenal
Founded Year 2013
Location France France
Employees 2
Industries Biotechnology, Health Care, Health and Wellness
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with CardioRenal. To contact CardioRenal, visit cardio-renal.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does CardioRenal compare?

A PDF of CardioRenal and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting CardioRenal soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About CardioRenal

CardioRenal is a biotechnology startup based in France, founded in 2013, focusing on digital therapeutics for chronic cardiovascular disease. The company is dedicated to leveraging advanced technology, including expert systems, real-time diagnosis, and microfluidics, in conjunction with leading medical expertise to enhance the quality of treatment for heart failure patients. In their pursuit, CardioRenal has developed a telemedicine solution for measuring biomarkers in patients at home, enabling real-time therapy adjustments based on the patient's condition. Targeting heart failure patients, the company aims to scale up commercialization relatively quickly through a licensing agreement with a pharmaceutical laboratory. Notably, CardioRenal secured a significant €3.30M in a Seed Round investment on 04 April 2022, signaling investor confidence in the company's innovative approach to cardiovascular disease treatment.

Business keywords: digital therapeutics, cardiovascular disease, telemedicine, biomarker measurement, personalized medicine, heart failure, chronic kidney disease, expert systems, real-time diagnosis, microfluidics, medical expertise, commercialization strategy, pharmaceutical partnership, AI health, home-based patient care

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round €3.30M -
04 Apr 2022
Non Equity Assistance Undisclosed 1
Incubateur Lorrain
30 Dec 2012

CardioRenal Alternatives & Competitors

View All Alternatives
CardioRenal vs
DEARhealth
DEARhealth The Netherlands

DEARhealth biedt dynamische en risicogebaseerde zorgpaden en slimme beslissingsondersteuning voor me...

Acquired
9 employees
Health Care, Health and Wellness
CardioRenal vs
Access for Life
Access for Life United States

The JEM represents an innovative breakthrough in the field of repetitive vascular accessand real-tim...

Non Equity Assistance
9 employees
Biotechnology, Health Care
CardioRenal vs
Doctor Insta
Doctor Insta India

Bringing Healthcare to Everyone's fingertaps; India's 1st Video Medicine Company where One can consu...

Series B
6 employees
Health Care, Health and Wellness
View all alternatives

FAQ About CardioRenal

Digital therapeutics for chronic cardiovascular disease
CardioRenal was founded in 2013.
CardioRenal is headquartered in France.
CardioRenal operates in Biotechnology, Health Care and Health and Wellness. Its work centres on digital therapeutics, cardiovascular disease, telemedicine and biomarker measurement.
CardioRenal has approximately 2 employees.
CardioRenal has completed 2 funding rounds, raising a total of $3.30M. The latest funding stage is Seed.
Top alternatives and competitors to CardioRenal include DEARhealth, Access for Life, Doctor Insta, Bloomer Tech, Griffin Concierge Medical. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
CardioRenal and DEARhealth are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for CardioRenal, https://bouncewatch.com/company/cardiorenal, updated 11 June 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes